Delivery Order SPE2DB20D3103-SPE2DB24FL9J2
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,670.98 firm fixed-price delivery order is for the supply of 4 mg Ondansetron HCL tablets. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, running through November 2026. This IDC serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,146.74 firm fixed-price delivery order is for the supply of 4 mg Ondansetron HCL tablets to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,418.29 firm fixed-price delivery order is for the supply of 4 mg Ondansetron HCL tablets. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,136.32, is for the delivery of 4 mg Ondansetron HCL tablets to support military healthcare programs. This award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This federal contract award to Amerisourcebergen Drug Corporation (a major pharmaceutical distributor) was issued by the Defense Logistics Agency (DLA) Troop Support Medical. It is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The specific contract award is for the supply of 4,565,468,004 units of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,981.77 firm fixed-price delivery order is for the supply of 4,567,060 units of 4 mg Ondansetron HCL tablets, with a completion date of January 28, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,979.20 firm fixed-price delivery order is for the supply of Ondansetron HCL 8 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,757.50 Firm Fixed Price Delivery Order contract is for the supply of ondansetron ODT 4 mg tablets to support federal healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,685.69 firm fixed-price delivery order is for the supply of 4 mg Ondansetron HCL tablets. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,914.83 delivery order contract is for the supply of 4,566,188,517 units of 8 mg Ondansetron HCL tablets, with a period of performance ending on October 24, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FL9J2Delivery Order
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,905.39 firm fixed-price contract is for the supply of 8 mg Ondansetron HCL tablets to support military healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to the military. This IDC, which runs through November 2026, covers critical medical commodities across multiple therapeutic areas. The contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there are no major subcontractors mentioned. The DLA, a defense agency, is the funding agency for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 12/15/23 |